Cited 12 times in
A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.